1 option
Angiogenesis Modulations in Health and Disease : Practical Applications of Pro- and Anti-angiogenesis Targets / edited by Shaker A. Mousa, Paul J. Davis.
- Format:
- Book
- Series:
- Biomedical and Life Sciences (Springer-11642)
- Language:
- English
- Subjects (All):
- Medicine.
- Neurosciences.
- Pharmacy.
- Life sciences.
- Biotechnology.
- Cytology.
- Biomedicine, general.
- Life Sciences, general.
- Cell Biology.
- Local Subjects:
- Biomedicine, general.
- Neurosciences.
- Pharmacy.
- Life Sciences, general.
- Biotechnology.
- Cell Biology.
- Physical Description:
- 1 online resource (X, 206 pages)
- Edition:
- First edition 2013.
- Contained In:
- Springer eBooks
- Place of Publication:
- Dordrecht : Springer Netherlands : Imprint: Springer, 2013.
- System Details:
- text file PDF
- Summary:
- This book is a major update of novel targets in angiogenesis modulation, including pro- and anti-angiogenesis. There is in-depth coverage of preclinical and clinical methods and models, investigational status, and clinical applications. The impact of nanotechnology in advancing the applications of pro-and anti-angiogenesis strategies is also highlighted, along with stem cell and biotechnologies in research and development of angiogenesis modulating targets.
- Contents:
- Preface
- Angiogenesis assays: an appraisal of current techniques
- Survey of pro-angiogenesis strategies
- Angiogenesis modulation by arachidonic acid - derived lipids: positive and negative regulators of angiogenesis
- Pro-angiogenic activity of thyroid hormone analogues: Mechanisms, physiology and clinical prospects
- Actions of steroids and peptide hormones on angiogenesis
- Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis modulation.- Catecholamine neurotransmitters: an angiogenic switch in the tumor microenvironment
- Impact of nanotechnology on therapeutic angiogenesis
- Survey of anti-angiogenesis strategies
- Tetraiodothyroacetic acid (tetrac), nanotetrac and anti-Angiogenesis
- Integrin antagonists and angiogenesis
- Anti-angiogenesis therapy as an adjunct to chemotherapy in oncology
- Anti-vegf strategies in ocular angiogenesis- mediated disorders, with special emphasis on age-related macular degeneration
- Application of nanotechnology to targeting tumor angiogenesis for therapeutic benefit
- Biomarkers of response and resistance to anti-angiogenic treatment
- Speculations on new directions in which angiogenesis may proceed. Index.
- Other Format:
- Printed edition:
- ISBN:
- 978-94-007-6467-5
- 9789400764675
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.